Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Senter

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 24, 2009
Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker systemPatrick J Burke, Brian E Toki, David W Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2010
Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugateNicole M Okeley, Jamie B Miyamoto, Xinqun Zhang, et al.
Molecular Cancer Therapeutics|March 14, 2020
Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary CancersMary L Disis, Lauren R Corulli, Ekram A Gad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugateRussell J Sanderson, Michelle A Hering, Stephanie F James, et al.
Plos One|February 24, 2015
The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle miceJohn D Belcher, Chunsheng Chen, Julia Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2020
Structure-activity relationships of tubulysin analoguesJoel R Courter, Joseph Z Hamilton, Nathaniel R Hendrick, et al.
Angewandte Chemie (International Ed. in English)|May 21, 2016
The Methylene Alkoxy Carbamate Self-Immolative Unit: Utilization for the Targeted Delivery of Alcohol-Containing Payloads with Antibody-Drug ConjugatesRobert V Kolakowski, Karl T Haelsig, Kim K Emmerton, et al.
Bioconjugate Chemistry|May 28, 2009
Design, synthesis, and biological evaluation of antibody-drug conjugates comprised of potent camptothecin analoguesPatrick J Burke, Peter D Senter, David W Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Chemotherapy delivery issues in central nervous system malignancy: a reality checkLeslie L Muldoon, Carole Soussain, Kristoph Jahnke, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolitesPeter D Senter, Yousef Al-Abed, Christine N Metz, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|April 24, 2009
Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker systemPatrick J Burke, Brian E Toki, David W Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2010
Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugateNicole M Okeley, Jamie B Miyamoto, Xinqun Zhang, et al.
Molecular Cancer Therapeutics|March 14, 2020
Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary CancersMary L Disis, Lauren R Corulli, Ekram A Gad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugateRussell J Sanderson, Michelle A Hering, Stephanie F James, et al.
Plos One|February 24, 2015
The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle miceJohn D Belcher, Chunsheng Chen, Julia Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2020
Structure-activity relationships of tubulysin analoguesJoel R Courter, Joseph Z Hamilton, Nathaniel R Hendrick, et al.
Angewandte Chemie (International Ed. in English)|May 21, 2016
The Methylene Alkoxy Carbamate Self-Immolative Unit: Utilization for the Targeted Delivery of Alcohol-Containing Payloads with Antibody-Drug ConjugatesRobert V Kolakowski, Karl T Haelsig, Kim K Emmerton, et al.
Bioconjugate Chemistry|May 28, 2009
Design, synthesis, and biological evaluation of antibody-drug conjugates comprised of potent camptothecin analoguesPatrick J Burke, Peter D Senter, David W Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Chemotherapy delivery issues in central nervous system malignancy: a reality checkLeslie L Muldoon, Carole Soussain, Kristoph Jahnke, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolitesPeter D Senter, Yousef Al-Abed, Christine N Metz, et al.
Pageof 9